Key result
OxLDL-activated monocytes drive VSMC phenotypic switching and plaque destabilization via NLRP3 inflammasome activation.
Why the study?
It remained to be investigated whether monocytes and NLRP3 inflammasome activation are direct triggers of vascular smooth muscle cell phenotypic switch and plaque disruption.
Does monocyte-induced NLRP3 inflammasome activation promote vascular smooth muscle cell phenotypic switch in atherosclerosis?
Does monocyte-induced NLRP3 inflammasome activation promote vascular smooth muscle cell phenotypic switch in atherosclerosis?
Monocyte-induced NLRP3 inflammasome activation drives vascular smooth muscle cell phenotypic switching, highlighting a mechanism for atherosclerotic plaque destabilization.
Answers are grounded in this paper and cite their sources.
NLRP3 activation by monocytes may promote plaque destabilization; leaves open therapeutic targeting pending clinical trials.
(1) Background: Monocytes and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome orchestrate lipid-driven amplification of vascular inflammation promoting the disruption of the fibrous cap. The components of the NLRP3 inflammasome are expressed in macrophages and foam cells within human carotid atherosclerotic plaques and VSMCs in hypertension. Whether monocytes and NLRP3 inflammasome activation are direct triggers of VSMC phenotypic switch and plaque disruption need to be investigated. (2) Methods: The direct effect of oxLDL-activated monocytes in VSMCs co-cultured system was demonstrated via flow cytometry, qPCR, ELISA, caspase 1, and pyroptosis assay. Aortic roots of VSMCs lineage tracing mice fed normal or high cholesterol diet and human atherosclerotic plaques were used for immunofluorescence quantification of NLRP3 inflammasome activation/VSMCs phenotypic switch. (3) Results: OxLDL-activated monocytes reduced α-SMA, SM22α, Oct-4, and upregulation of KLF-4 and macrophage markers MAC2, F4/80 and CD68 expression as well as caspase 1 activation, IL-1β secretion, and pyroptosis in VSMCs. Increased caspase 1 and IL-1β in phenotypically modified VSMCs was detected in the aortic roots of VSMCs lineage tracing mice fed high cholesterol diet and in human atherosclerotic plaques from carotid artery disease patients who experienced a stroke. (4) Conclusions: Taken together, these results provide evidence that monocyte promote VSMC phenotypic switch through VSMC NLRP3 inflammasome activation with a likely detrimental role in atherosclerotic plaque stability in human atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Burger et al. (2021) studied Atherosclerosis and Carotid Artery Disease (n=24). OxLDL-activated monocytes and NLRP3 inflammasome activation vs. Unexposed cells or normal cholesterol diet was evaluated on Vascular smooth muscle cell (VSMC) phenotypic switch to macrophage-like cells. OxLDL-activated monocytes promote vascular smooth muscle cell phenotypic switch and foam cell formation through NLRP3 inflammasome activation, contributing to atherosclerotic plaque destabilization.
Synapse has enriched 10 related papers. Consider them for comparative context: